Tetraphase Pharmaceuticals
Xerava Effective in Eradicating Organism, Curing cIAIs
Xerava showed similar eradication results as the comparator agents in patients with cIAIs.
NOVEMBER 12, 2018
FDA Approves Xerava for Complicated Intraabdominal Infections
The FDA approved Xerava to treat complicated intraabdominal infections in those 18 years old and older.
AUGUST 28, 2018
Load more